Whitepaper: Do you know what’s going in? Analysing tablets by NIR spectroscopy
Posted: 13 December 2017 | Metrohm | No comments yet
Drug analysis needs to be cost effective without compromising on accuracy…
This is an important principle for both routine quality control and the identification of potentially harmful counterfeit medicines. Near-infrared spectroscopy, or NIRS for short, is a useful part of the pharmaceutical analysis toolbox – and a winning choice thanks to the minimal time and labour resources it consumes, as well as the fully automated online analyses it offers.
Not only that, but it also takes simultaneous analysis of multiple substances in its stride. This article illustrates what it can do.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- Analysis of impurities in pharmaceuticals using ion chromatography
- Quantitative transmission Raman for content uniformity testing
- Metrohm USA contributes to global monograph modernisation initiative
- New Metrohm Mira P for raw material verification
- Metrohm acquires innovative Photonic Solutions to expand Handheld Raman portfolio
Related topics
Analytical techniques, Drug Manufacturing, QA/QC, Technology
